The panels provide clinicians, patients, and payers greater flexibility to access high-quality, affordable genetic information across a larger number of metabolic disorders and newborn screening options as well asimmunological disorders, all at the same price. Results are provided quickly, within 14 days on average.
Highlights of this expansion include:
Comprehensive coverage of both common and rare lysosomal storage disorders (LSDs)
Expanded metabolic newborn screening confirmation panel that includes X-linked adrenoleukodystrophy, LSDs, and acidemias
New treatable neurometabolic disorders panel to enable early diagnosis
New panels covering peroxisomal, neurotransmitter, glycogen storage, and other rare metabolic disorders
New panels covering primary immunodeficiencies and other immunological disorders